Replimune News, Replimune Quote, REPL Quote

Replimune (NQ:REPL) Delayed: 6.30 -0.12 (1.87%)

Prev. Close

$6.42

Open

$6.41

52 Wk High

$1.45

52 Wk Low

$0.50

Day High

$6.66

Day Low

$6.20

P/E

N/A

EPS

$0.00

Volume

231,835

Friends, Peers and Foes (?): COYA, INCY, NAMS, PLRX, MRTX (more...)

Apr 10, 2024 12:59 PM Form SC 13G/A Replimune Group, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Apr 10, 2024 09:49 AM Form SC 13G/A Replimune Group, Inc. Filed by: STATE STREET CORP
Apr 7, 2024 05:00 PM Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Asso
Apr 4, 2024 08:00 AM Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 3, 2024 08:05 PM Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Peeples-Dyer Veleka
Apr 3, 2024 08:04 PM Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Patel Sushil
Apr 3, 2024 08:03 PM Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Pucci Paolo
Apr 3, 2024 08:03 PM Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Xynos Konstantinos
Apr 3, 2024 08:02 PM Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Dhingra Kapil
Apr 3, 2024 08:02 PM Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Hill Emily Luisa

Entities mentioned with REPL